ClinicalTrials.gov New Studies Tracker: New Clinical Trials with Sponsor Rollup

ClinicalTrials.gov scraper for newly registered studies, read from the official ClinicalTrials.gov API v2: NCT id, sponsor, phase, status, conditions, interventions, enrollment and key dates, with an opportunity score and an optional one-row-per-sponsor rollup.

This Actor vs parseforge/clinicaltrials-scraper: that one is the most-used and also returns eligibility, contacts and locations. Choose this one for a feed of newly posted studies with phase and status filters, an opportunity score and a sponsor rollup, with no personal contact data.

Pull newly registered clinical studies from ClinicalTrials.gov into a clean table. Each row has the NCT id, title, lead sponsor, phase, status, conditions, interventions, enrollment, start date, first posted date, primary completion date, countries, a link to the study and a simple recency and opportunity score. Turn on the sponsor rollup to get one row per sponsor instead. Data comes from the free public ClinicalTrials.gov API v2. No login, no proxy, no key.

What does this Actor do?

It calls clinicaltrials.gov/api/v2/studies for studies whose first-posted date falls in the window you choose (default: the last 30 days), reads only the study fields listed below, scores each study and returns the best-scoring studies first. You can narrow by search term, phase, status and minimum score. It never requests investigator, contact or facility-contact fields, so no personal names, emails or phone numbers are returned. The actor reports what the registry publishes. It adds no medical advice.

Run in 30 seconds

1. Open the Actor and press Try for free (a free Apify account is enough).
2. Keep the prefilled input (last 30 days, 100 rows) and press Start.
3. Open the Output tab. Use the table view or download CSV, Excel or JSON.

Input

Field	What it does
daysBack	Keep studies first posted in the last N days. Default 30.
searchTerm	Optional ClinicalTrials.gov search expression, for example diabetes.
phases	Optional list: EARLY_PHASE1, PHASE1, PHASE2, PHASE3, PHASE4, NA.
statuses	Optional list such as NOT_YET_RECRUITING, RECRUITING.
minOpportunityScore	Optional 0 to 100 threshold.
sponsorRollup	Return one row per lead sponsor instead of one row per study.
maxItems	Stop after this many rows. Default 100.

Sample input:

{
  "daysBack": 14,
  "searchTerm": "obesity",
  "phases": ["PHASE2", "PHASE3"],
  "maxItems": 50
}

Output

One row per study:

Field	Meaning
nctId, studyUrl	The registry id and a link to the study page.
title	Brief title.
sponsor, sponsorClass	Lead sponsor organization and its class (INDUSTRY, NIH, OTHER and so on).
phase, status	Study phase and overall recruitment status.
conditions, interventions	Conditions studied and intervention names.
enrollment	Planned or actual enrollment count.
startDate, firstPostedDate, primaryCompletionDate	Key dates (ISO; some are month precision).
countries	Countries with listed study locations.
daysSincePosted	Age of the registration.
opportunityScore	0 to 100, see below.
scrapedAt	When the run read the data.

With sponsorRollup on, each row is a sponsor: sponsor, sponsorClass, studyCount, totalEnrollment, phases, topConditions, latestFirstPostedDate, maxOpportunityScore, nctIds (up to 25) and sponsorUrl.

Sample output

{
  "nctId": "NCT07841106",
  "title": "Early Prophylactic Versus Late Salvage Recombinant Human Endostatin in Managing Radiosurgery-Induced Brain Injury for NSCLC Brain Metastases",
  "sponsor": "Jiangmen Central Hospital",
  "sponsorClass": "OTHER",
  "phase": "Phase 2",
  "status": "NOT_YET_RECRUITING",
  "conditions": ["Lung Cancer (Non-Small Cell)", "Brain Injury"],
  "interventions": ["Recombinant Human Endostatin (Endostar)"],
  "enrollment": 49,
  "startDate": "2026-09-01",
  "firstPostedDate": "2026-09-25",
  "primaryCompletionDate": "2028-04-30",
  "studyUrl": "https://clinicaltrials.gov/study/NCT07841106",
  "opportunityScore": 56
}

Use cases

• Business development teams at CROs, labs and suppliers: spot sponsors who just registered Phase 2 and 3 trials and are about to need sites, vendors or services.
• Biotech and pharma competitive intelligence: watch new studies in a condition or drug class with a weekly scheduled run.
• Investors and analysts: use the sponsor rollup to see which companies are registering the most new studies this month.
• Patient advocacy and research groups: list newly posted, not yet recruiting studies for a condition.

Opportunity score

A fixed rule of thumb, not a clinical or financial rating. Up to 40 points for recency (linear over 60 days), 20 for not yet recruiting or 18 for recruiting (10 enrolling by invitation, 5 active not recruiting), up to 15 for phase (Phase 3 highest), up to 15 for planned enrollment size, and 10 if the lead sponsor is industry. Capped at 100. The same inputs always give the same score on the same day.

Why use it

• Official source. Data is the ClinicalTrials.gov registry as published through its public API.
• Ready to filter. Dates in ISO format, one row per study, scores for sorting.
• Sponsor view. The rollup turns thousands of studies into a short list of active sponsors.

Pricing

Pay per event. You pay a small fixed amount per row delivered, listed on the Pricing tab, plus a tiny start fee per run. You can set a maximum cost per run in the run options.

FAQ

How fresh is the data? New registrations appear on ClinicalTrials.gov on the business days after review. firstPostedDate is the date the registry first published the study.

Why do I get fewer rows than maxItems? Only studies posted inside your window and matching your filters exist. Try a larger daysBack or remove filters.

Does it include contact people? No. Investigator, official and contact names, emails and phone numbers are not requested or returned.

Is this an official ClinicalTrials.gov or NIH product? No. It is an independent tool that reads the public API. Check the registry for authoritative records.

Limits

• Covers studies registered on ClinicalTrials.gov only; other registries are not included.
• Registry data is sponsor-reported and may be incomplete or change. Do not use it for medical decisions.
• Rollup mode reads up to 20,000 studies per run.

Related Actors

• FDA Recalls and Enforcement Reports Tracker lists FDA drug, device and food recalls with a severity score.
• Developer Signals tracks public developer activity signals for companies.
• Sitemap Link Inventory lists every URL a site publishes in its sitemaps.

Found a bug or need a field? Open an issue on the Issues tab with the run URL.

More from DWA Open Data

Browse all 69 data Actors, with live prices and sample output, at open-data-actors.pages.dev.

---

Feedback: if this Actor was useful, or if it fell short, an honest review on the Reviews tab helps other users decide. Problems or feature requests: please open an Issue and we usually reply within one business day.